Addex Therapeutics to Release Q1 2024 Financial Results and

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...

Related Keywords

United States , Switzerland , Geneva , Genè , American , Swiss , Mikhail Kalinichev , Tim Dyer , Mike Sinclair , Nasdaq , Swiss Exchange , Janssen Pharmaceuticals Inc , Translational Science , Addex Therapeutics , Conference Call , Participant Dial In , American Depositary Shares , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,